Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1998 Oct-Dec;4(4):635–639. doi: 10.3201/eid0404.980415

Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany.

L Beutin 1, S Zimmermann 1, K Gleier 1
PMCID: PMC2640265  PMID: 9866741

Abstract

We investigated different types of Shiga toxin-producing Escherichia coli (STEC) not belonging to serogroup O157 for their role as human pathogens. Non-O157 STEC isolated from 89 human patients in Germany were characterized according to serotypes, virulence markers, and association with human illness. EaeA-positive STEC were isolated from 54 (60.7%) of the patients and were frequently associated with severe diarrheal disease, hemolytic uremic syndrome, and young age. EaeA-negative STEC were found in 35 (39.3%) of the patients and were more associated with clinically uncomplicated cases and adult patients. For pediatric patients, a serotype-independent diagnosis of STEC is recommended.

Full Text

The Full Text of this article is available as a PDF (54.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beebakhee G., Louie M., De Azavedo J., Brunton J. Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7. FEMS Microbiol Lett. 1992 Feb 1;70(1):63–68. doi: 10.1016/0378-1097(92)90563-4. [DOI] [PubMed] [Google Scholar]
  2. Beutin L., Geier D., Zimmermann S., Karch H. Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol. 1995 Mar;33(3):631–635. doi: 10.1128/jcm.33.3.631-635.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Griffin P. M., Tauxe R. V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98. doi: 10.1093/oxfordjournals.epirev.a036079. [DOI] [PubMed] [Google Scholar]
  4. Gunzer F., Böhm H., Rüssmann H., Bitzan M., Aleksic S., Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992 Jul;30(7):1807–1810. doi: 10.1128/jcm.30.7.1807-1810.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Karmali M. A. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev. 1989 Jan;2(1):15–38. doi: 10.1128/cmr.2.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schmidt H., Plaschke B., Franke S., Rüssmann H., Schwarzkopf A., Heesemann J., Karch H. Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med Microbiol Immunol. 1994 Feb;183(1):23–31. doi: 10.1007/BF00193628. [DOI] [PubMed] [Google Scholar]
  7. Tarr P. I. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis. 1995 Jan;20(1):1–10. doi: 10.1093/clinids/20.1.1. [DOI] [PubMed] [Google Scholar]
  8. Wilson J. B., Clarke R. C., Renwick S. A., Rahn K., Johnson R. P., Karmali M. A., Lior H., Alves D., Gyles C. L., Sandhu K. S. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis. 1996 Nov;174(5):1021–1027. doi: 10.1093/infdis/174.5.1021. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES